SEL-110
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SEL-110, covering 2019-11-22 to 2019-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma [Phase 1]